An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer
Henriksen, Katrine L., Rasmussen, Birgitte B., Lykkesfeldt, Anne E., Møller, Susanne, Ejlertsen, Bent, Mouridsen, Henning T.Volume:
48
Language:
english
Journal:
Acta Oncologica
DOI:
10.1080/02841860802676383
Date:
January, 2009
File:
PDF, 223 KB
english, 2009